🇺🇸 FDA
Company

Arcus

Arcus Biosciences

RCUS pharma USA

Quick answer

Arcus is a pharma company (RCUS) headquartered in HAYWARD, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Casdatifan

Metastatic Clear Cell Renal Cell Carcinoma

Phase 3 · small_molecule · active

1 trials project

Domvanalimab

Advanced Upper Gastrointestinal Tract Adenocarcinoma

Phase 3 · small_molecule · active

1 trials project

Durvalumab

Non-Small Cell Lung Cancer

Phase 3 · small_molecule · active

1 trials project

Quemliclustat

Metastatic Pancreatic Ductal Adenocarcinoma

Phase 3 · small_molecule · active

1 trials project

Volrustomig

Advanced Clear Cell Renal Cell Carcinoma

Phase 3 · small_molecule · active

1 trials project

Zimberelimab

Non-small Cell Lung Cancer

Phase 3 · small_molecule · active

2 trials project

AB680

Metastatic Colorectal Cancer

Phase 2 · small_molecule · completed

1 trials project

Atezolizumab

Prostate Adenocarcinoma

Phase 2 · small_molecule · active

1 trials project

Casdatifan

Renal Cell Carcinoma

Phase 2 · small_molecule · active

1 trials project

Domvanalimab

Head and Neck Squamous Cell Carcinoma

Phase 2 · small_molecule · active

1 trials project

Domvanalimab

Non Small Cell Lung Cancer

Phase 2 · small_molecule · active

2 trials project

Domvanalimab

Advanced Non-Small Cell Lung Cancer

Phase 2 · small_molecule · active

1 trials project

Domvanalimab

Gastrointestinal Tract Malignancies

Phase 2 · small_molecule · active

1 trials project

Etrumadenant

Prostatic Neoplasms, Castration-Resistant

Phase 2 · small_molecule · completed

1 trials project

Etrumadenant (AB928)

Rectal Cancer

Phase 2 · small_molecule · active

1 trials project

Fluorouracil

Borderline Resectable Pancreatic Adenocarcinoma

Phase 2 · small_molecule · active

1 trials project

Gemcitabine

Biliary Tract Carcinoma

Phase 2 · small_molecule · active

1 trials project

Quemliclustat

Oligometastatic Prostate Cancer

Phase 2 · small_molecule · active

1 trials project

SRF617

Metastatic Castration-resistant Prostate Cancer

Phase 2 · small_molecule · terminated

1 trials project

ZIMBERELIMAB

Pancreatic Cancer

Phase 2 · small_molecule · on_hold

1 trials project

Zimberelimab

Melanoma

Phase 2 · small_molecule · active

1 trials project

Zimberelimab

Pancreatic Ductal Adenocarcinoma

Phase 2 · small_molecule · active

1 trials project

Zimberelimab

Hepatobiliary Cancer

Phase 2 · small_molecule · active

1 trials project

Zimberelimab

Adenocarcinoma Stomach

Phase 2 · small_molecule · terminated

1 trials

Patents (8)

patent

US 12415854

Antibodies to TIGIT

Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12410170

2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12384773

Thiazole compounds and methods of use thereof

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12310965

Treatment of cancer utilizing an identified adenosine fingerprint

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12281136

Crystalline forms of a CD73 inhibitor and uses thereof

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12226425

Inhibitors of ARG1 and/or ARG2

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12195447

Azolopyrimidine for the treatment of cancer-related disorders

Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12168023

Inhibitors of adenosine 5′-nucleotidase

Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)